title: Lessons from Lisbon on AHF drug treatment: is it really true that all-old-failed-all-new-will-succeed?
authors.affiliation: Critical Care Proprietary Products Division, Orion Pharma, PO Box 65, FIN-02101 Espoo, Finland. Electronic address: piero.pollesello@orionpharma.com.
authors.forename: Piero
authors.initials: P
authors.lastname: Pollesello
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Papp
authors.forename: Markku S
authors.initials: MS
authors.lastname: Nieminen
mesh_terms: D000208:Acute Disease; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D055808:Drug Discovery; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans
chemical_list: D002316:Cardiotonic Agents
keywords: Acute heart failure; Drug discovery and development; Drug therapies; Inodilators; Inotropes